Select Medical Holdings Corporation: Q1 2026 Financial Report – Key Investor Highlights

Overview

Select Medical Holdings Corporation has released its unaudited condensed consolidated financial statements for the quarter ended March 31, 2026. As a large accelerated filer, the company continues to meet all SEC reporting and interactive data submission requirements, demonstrating robust compliance and transparency. This quarterly report contains several important financial metrics and corporate developments that investors should closely monitor.

Key Financial Highlights

• Quarterly Net Income:
  • Net income attributable to Select Medical Holdings Corporation for Q1 2026 was \$43,995,000.
  • Consolidated net income for the period was \$63,775,000.
  • Basic and diluted earnings per share for Q1 2026 were \$0.35.
  • Comprehensive income net of tax totaled \$45,019,000.
• Balance Sheet Strength:
  • Total assets reported at \$6,042,083,000 as of March 31, 2026, compared to \$5,851,589,000 at December 31, 2025.
  • Total equity increased to \$2,016,931,000 from \$1,756,021,000 at year-end 2025.
  • Retained earnings rose to \$872,222,000, up from \$837,016,000 at the end of last year.
  • Non-controlling interests amounted to \$328,953,000, up from \$311,347,000.
• Dividends and Shareholder Returns:
  • Cash dividends declared for common stockholders for the quarter were \$0.0625 per share.
  • Total dividend payout was \$7,751,000 for Q1 2026.
  • The company also repurchased and retired stock valued at \$11,389,000 during the quarter.
• Equity Changes:
  • Issuance of restricted stock awards and vesting contributed to changes in additional paid-in capital, with \$4,638,000 added in Q1 2026.
  • Issuance of non-controlling interests from subsidiary equity amounted to \$9,569,000 in Q1 2026.
• Comprehensive Income and Derivatives:
  • Loss on interest rate cap contracts (cash flow hedge) after tax: (\$3,106,000) for Q1 2026.
  • Other comprehensive loss (net of tax) amounted to \$1,324,000 for the quarter.

Segment Reporting

The company reported three business segments for the quarter, reflecting its diversified operations and revenue streams.

Shareholder & Price-Sensitive Issues

• Strong Earnings Growth: The significant increase in net income and retained earnings signals improved profitability, which could positively affect share value.
• Dividend and Buybacks: Continued dividend payments and share repurchases are direct returns to shareholders and may support or boost the stock price.
• Balance Sheet Expansion: Growth in total assets and equity is a positive sign of financial strength and stability.
• Derivative Losses: The loss on cash flow hedges might be viewed as a risk factor by investors, although the amount is not large relative to net income.
• Non-controlling Interests: The increase in non-controlling interests suggests expansion or new investments in subsidiaries, indicating growth opportunities.
• Stock Repurchase: The repurchase and retirement of shares may signal management confidence in the company’s future and can be price supportive.

Potential Share Price Drivers

• Strong earnings and equity growth are key positive drivers.
• Dividend policy and share buybacks can attract income-focused investors.
• Derivative losses and comprehensive income fluctuations are risks that investors should monitor.
• Expansion of non-controlling interests could signify strategic growth, which may be viewed positively.

Conclusion

Select Medical Holdings Corporation’s Q1 2026 financial results show robust growth in earnings, equity, and retained earnings, alongside continued shareholder-friendly initiatives like dividends and buybacks. While derivative losses are notable, they are not sufficient to offset the overall positive financial momentum. Investors should view the results as supportive of share value, with ongoing growth and expansion efforts providing further upside potential.

Disclaimer: This article is based on unaudited financial statements and public disclosures. It does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making any investment decisions.

View SELECT MEDICAL HOLDINGS CORP Historical chart here